Quarter For Vanda Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quarter for vanda pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quarter For Vanda Pharmaceuticals Today - Breaking & Trending Today

Profit Investment Management LLC Cuts Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Profit Investment Management LLC lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 1.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 328,668 shares of the biopharmaceutical company’s stock after selling 4,195 shares during the period. Vanda Pharmaceuticals […] ....

Stephen Ray Mitchell , Panagora Asset Management Inc , Yousif Capital Management , Commonwealth Of Pennsylvania Public School Empls Retrmt , Securities Exchange Commission , Vanda Pharmaceuticals Inc , Vanda Pharmaceuticals Price Performance , Exchange Commission , Metlife Investment Management , News Ratings For Vanda Pharmaceuticals Daily , Jpmorgan Chase Co , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals , Profit Investment Management , Vanda Pharmaceuticals Profile , Free Report , Investment Management , Life Investment Management , Asset Management , Pennsylvania Public School Empls Retrmt , Capital Management , Get Free Report , Director Stephen Ray Mitchell , Pharmaceuticals Inc , Vanda Pharmaceuticals Daily , Nasdaq Vnda ,

Insider Selling: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CMO Sells 3,724 Shares of Stock

Insider Selling: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CMO Sells 3,724 Shares of Stock
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Joakim Wijkstrom , Vanda Pharmaceuticals Trading Down , Envestnet Asset Management Inc , Yousif Capital Management , Summerhaven Investment Management , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals , News Ratings For Vanda Pharmaceuticals Daily , Vanda Pharmaceuticals Inc , Group Plc , Institutional Trading Of Vanda Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , Asset Management , Capital Management , General Group Plc , Haven Investment Management , Pharmaceuticals Inc , Vanda Pharmaceuticals Daily ,

Los Angeles Capital Management LLC Purchases 169,768 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Los Angeles Capital Management LLC raised its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 248.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 238,125 shares of the biopharmaceutical company’s stock after buying an additional 169,768 shares during the quarter. Los […] ....

Los Angeles , United States , Timothy Williams , Kevin Patrick Moran , Vanda Pharmaceuticals Inc , Insider Activity At Vanda Pharmaceuticals , Los Angeles Capital Management , News Ratings For Vanda Pharmaceuticals Daily , Commonwealth Of Pennsylvania Public School Empls Retrmt , Vanda Pharmaceuticals , Exchange Commission , Jpmorgan Chase Co , Yousif Capital Management , Panagora Asset Management Inc , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals Trading , Metlife Investment Management , Vanda Pharmaceuticals Company Profile , Free Report , Angeles Capital Management , Life Investment Management , Asset Management , Pennsylvania Public School Empls Retrmt , Capital Management , Get Free Report , Patrick Moran ,

Insider Selling: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) SVP Sells $95,776.00 in Stock

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) SVP Timothy Williams sold 14,600 shares of the firm’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $6.56, for a total value of $95,776.00. Following the transaction, the senior vice president now owns 88,913 shares in the company, valued […] ....

United States , Timothy Williams , Summerhaven Investment Management , Vanda Pharmaceuticals Company Profile , Mutual Of America Capital Management , Vanda Pharmaceuticals Stock Performance , Yousif Capital Management , News Ratings For Vanda Pharmaceuticals Daily , Quarter For Vanda Pharmaceuticals , Envestnet Asset Management Inc , Hedge Funds Weigh In On Vanda Pharmaceuticals , Group Plc , Vanda Pharmaceuticals Inc , Vanda Pharmaceuticals , Get Rating , Asset Management , Capital Management , General Group Plc , America Capital Management , Haven Investment Management , Vanda Pharmaceuticals Daily ,

Capital Advisors Ltd. LLC Purchases New Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Capital Advisors Ltd. LLC purchased a new stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,000 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other […] ....

Joakim Wijkstrom , Kevin Patrick Moran , Capital Advisors Ltd , Vanda Pharmaceuticals Inc , Securities Exchange Commission , News Ratings For Vanda Pharmaceuticals Daily , Legato Capital Management , Quarter For Vanda Pharmaceuticals , Vanda Pharmaceuticals Trading , Vanda Pharmaceuticals , Balyasny Asset Management , Capital Advisors , Get Rating , Asset Management , Exchange Commission , Patrick Moran , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,